Volume 69 Received 9 October 2012 | |||||||||||
| |||||||||||
2N)amino-
N]-N-(2,6-dimethylphenyl)acetamide-
O}(perchlorato-
O)zinc (acetonitrile){2-[bis(pyridin-2-ylmethyl-
2N)amino-
N]-N-(2,6-dimethylphenyl)acetamide-
O}zinc tris(perchlorate)aSchool of Pharmacy, University of Oslo, PO Box 1068 Blindern, N-0316 Oslo, Norway, and bDepartment of Chemistry, University of Oslo, PO Box 1033 Blindern, N-0315 Oslo, Norway
Correspondence e-mail: pal.rongved@farmasi.uio.no
In the title salt, [Zn(C22H24N4O)(CH3CN)][Zn(ClO4)(C22H24N4O)(CH3CN)](ClO4)3, two differently coordinated zinc cations occur. In the first complex, the metal ion is coordinated by the N,N',N'',O-tetradentate acetamide ligand and an acetonitrile N atom, generating an approximate trigonal-bipyramidal coordination geometry, with the O atom in an equatorial site and the acetonitrile N atom in an axial site. In the second complex ion, a perchlorate ion is also bonded to the zinc ion, generating a distorted trans-ZnO2N4 octahedron. Of the uncoordinating perchlorate ions, one lies on a crystallographic twofold axis and one lies close to a twofold axis and has a site occupancy of 0.5. N-H
O and N-H
(O,O) hydrogen bonds are observed in the crystal. Disordered solvent molecules occupy about 11% of the unit-cell volume; their contribution to the scattering was removed with the SQUEEZE routine of the PLATON program [Spek (2009
). Acta Cryst. D65, 148-155.].
For related structures found in the Cambridge Structural Database (Version 5.33 of November 2011; Allen, 2002
), see: Xu et al. (2010a
,b
); Patten et al. (2008
); Marlin et al. (2006
). For biochemical background, see: Makhov et al. (2008
); Xu et al. (2010a
).
|
|
| ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
Data collection: APEX2 (Bruker, 2007
); cell refinement: SAINT-Plus (Bruker, 2007
); data reduction: SAINT-Plus; program(s) used to solve structure: SHELXTL (Sheldrick, 2008
); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL and Mercury (Macrae et al., 2008
); software used to prepare material for publication: SHELXTL.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HB6972 ).
The work has been partly supported by Statoil Norge AS.
Allen, F. H. (2002). Acta Cryst. B58, 380-388.
![[details]](../../../../../../b/graphics/details.gif)
Bruker (2007). APEX2, SAINT-Plus and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.
![[details]](../../../../../../j/graphics/details.gif)
Makhov, P., Golovine, K., Uzzo, R. G., Rothman, J., Crispen, P. L., Shaw, T., Scoll, B. J. & Kolenko, V. M. (2008). Cell Death Differ. 15, 1745-1751.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Marlin, D. S., Cabrera, D. G., Leigh, D. A. & Slawin, A. M. Z. (2006). Angew. Chem. Int. Ed. 45, 77-83.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Patten, T. E., Olmstead, M. M. & Troeltzsch, C. (2008). Inorg. Chim. Acta, 361, 365-372.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Xu, Z., Baek, K.-H., Kim, H. N., Cui, J., Qian, X., Spring, D. R., Shin, I. & Yoon, J. (2010a). J. Am. Chem. Soc. 132, 601-610.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Xu, Z., Han, S. J., Lee, C., Yoon, J. & Spring, D. R. (2010b). Chem. Commun. 46, 1679-1682.
![[ChemPort]](../../../../../../logos/chemportborder.gif)